Figure 4.
Effect of central TUG-905 administration on the hypothalamus of obese mice. (A) Representative immunoblot images and (B) densitometry quantification of protein levels of inflammation markers in the MBH (n = 7 mice/group) of vehicle and TUG-905 ICV-treated DIO mice. (C) Representative immunoblot images and (D) densitometry quantification of protein levels of pAMPK and ER stress markers in the MBH (n = 6–8 mice/group) of vehicle and TUG-905 ICV-treated DIO mice. Data are expressed as MEAN ± SEM. Statistical significance was determined by Student's t-test ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. vehicle.